Tessera Therapeutics’ $300 Million Series C Financing

Martina Bellini
Tagged:

Goodwin advised Tessera Therapeutics on the deal.Tessera Therapeutics announced its Series C financing, which totaled over $300 million. Tessera is a biotechnology company pioneering a new…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now